# Gliflozins and Cardiovascular Risk Factors in Type 2 Diabetes (GIOIA)

> **NCT03918148** · — · COMPLETED · sponsor: **University of Campania Luigi Vanvitelli** · enrollment: 1150 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** SGLT-2i
- **DRUG:** DPP-4i

## Key facts

- **NCT ID:** NCT03918148
- **Lead sponsor:** University of Campania Luigi Vanvitelli
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-15
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 1150 (ACTUAL)
- **Last updated:** 2024-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03918148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03918148, "Gliflozins and Cardiovascular Risk Factors in Type 2 Diabetes (GIOIA)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03918148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*